Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
Mark W. Tenforde, Manish M. Patel, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 4, pp. 118-124
Open Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus
Jun Kikuchi, Yasushi Kondo, Shuichiro Kojima, et al.
Immunological Medicine (2024) Vol. 47, Iss. 2, pp. 76-84
Open Access | Times Cited: 3
Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents
Yoo-Yeon Kim, Young June Choe, Jia Kim, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 11, pp. 2165-2170
Open Access | Times Cited: 16
A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine
Giancarlo Ripabelli, Michela Lucia Sammarco, Giovanni Rezza, et al.
Journal of Community Health (2022) Vol. 47, Iss. 4, pp. 598-603
Open Access | Times Cited: 15
Breakthrough SARS-CoV-2 infections after COVID-19 immunization
Joshua Hirsh, Thwe Htay, Shubhang Bhalla, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 6, pp. 1429-1432
Open Access | Times Cited: 14
Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
Ana Florea, Lina S. Sy, Lei Qian, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 2, pp. 252-262
Open Access | Times Cited: 14
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Keya Joshi, Stefan Scholz, Michael Maschio, et al.
Journal of Medical Economics (2023) Vol. 27, Iss. 1, pp. 39-50
Open Access | Times Cited: 8
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
Kanal Singh, Joseph M. Rocco, Véronique Nussenblatt
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 321-332
Closed Access | Times Cited: 2
Social Support Mediates the Relationship between COVID-19-Related Burnout and Booster Vaccination Willingness among Fully Vaccinated Nurses
Petros Galanis, Aglaia Katsiroumpa, Panayota Sourtzi, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 46-46
Open Access | Times Cited: 12
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications
Claire Cook, Naomi J. Patel, Xiaoqing Fu, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 5, pp. 697-703
Open Access | Times Cited: 7
COVID-19 Vaccines—All You Want to Know
Akira Shishido, Ashley H. Barnes, Shivakumar Narayanan, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 143-172
Closed Access | Times Cited: 7
Association Between the “We Can Do This” Campaign and COVID-19 Booster Uptake, U.S., 2021–2022
Benjamin Denison, Morgane Bennett, Jae-Eun C. Kim, et al.
AJPM Focus (2024) Vol. 3, Iss. 2, pp. 100183-100183
Open Access | Times Cited: 2
Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan
Tetsuya Akaishi, Shigeki Kushimoto, Yukio Katori, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Nathaniel M. Lewis, Nancy L. Murray, Katherine Adams, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021
Peter J. Embí, Matthew E. Levy, Palak Patel, et al.
Vaccine (2023) Vol. 41, Iss. 37, pp. 5424-5434
Open Access | Times Cited: 6
Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations
J. Daniel Kelly, Samuel Leonard, W. John Boscardin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Primary care physicians’ strategies for addressing COVID-19 vaccine hesitancy
Tasmiah Nuzhath, Abigail Spiegelman, Julia Scobee, et al.
Social Science & Medicine (2023) Vol. 333, pp. 116150-116150
Closed Access | Times Cited: 6
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
Philippe Halfon, Sylvie Jordana, Stéphane Blachier, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0281257-e0281257
Open Access | Times Cited: 5
Obesity and Viral Infections
Priya Jaisinghani, Rekha B. Kumar
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 2, pp. 393-402
Open Access | Times Cited: 5
Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
Tianyu Sun, Linwei Li, Katherine E. Mues, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Vaccination and its impact on healthcare utilization in two groups of vaccinated and unvaccinated patients with COVID‐19: A cross‐sectional study in Iran between 2021 and 2022
Erfan Kharazmi, Mohsen Bayati, Ali Shirazi
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 1
Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up
Benjamin Siebald, Andreas H. Groll, Sarah Salou, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Open Access | Times Cited: 1
The Safety of Covishield (ChAdOx1 nCoV-19) Vaccine after Three Doses Vaccination under Mass Vaccination Program of Government of India
Narinder Singh, Jaswinder Singh, Vikram Bhandari, et al.
AMEI s Current Trends in Diagnosis & Treatment (2024) Vol. 7, Iss. 2, pp. 36-42
Open Access | Times Cited: 1
The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
Uptake of COVID-19 booster shot among healthcare workers: A mediation analysis approach
Shazia Rehman, Erum Rehman, Jianglin Zhang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 8

Scroll to top